November 2022

Editorial Board

Multicenter validation of 18F-DCFPyL radiomics-based machine learning models in intermediate - To high risk primary prostate cancer

• W. Luining,
• M.C.F. Cysouw,
• D.E. Oprea-Lager,
• A.N. Vis,
• R. Boellaard

Defining the role of preoperative multiparametric Magnetic Resonance Imaging (mpMRI) to predict extracapsular extension in radical prostatectomy specimen

• F. Sanguedolce,
• A. Tedde,
• M. Tedde,
• ...
• E. Suquilanda,
• J. Palou,
• A. Breda

The immunohistochemical expression of IGF-1Ec in prostate cancer

• N. Alevizopoulos,
• A. Armakolas,
• A. Filippou,
• ...
• A. Sepsa,
• C. Petraki,
• M. Koutsilieris

The membranous urethral length: A continence predictor on MRI with high interobserver variability

• M.J. Hagens,
• H. Veerman,
• A.N. Vis,
• ...
• B.W.K. De Wit,
• P.J. Van Leeuwen,
• H.G. Van Der Poel

Factors affecting recurrence in nephron-sparing surgery and ablative methods in small kidney tumors (pT1a): Our single center experiences

• M.O. Atacer,
• B. Bilir,
• T. Aktoz,
• E. Arda

Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?

• P. Ramos,
• A. Mateus,
• L. Vale,
• ...
• S. Silva,
• L. Pacheco-Figueiredo,
• C. Silva

Studying the wnt/beta- catenin and microrna signaling crosstalk in CTNNB1and ABCG2 genes expression in prostate cancer

• A. Khan,
• M.N. Faisal,
• B. Aslam,
• ...
• L. Majeed,
• N. Ahmad,
• U. Haider

Choline PET/CT radiomic analysis for newly diagnosed prostate cancer: An early monocentric experience

• R. Bientinesi,
• D.A. Pizzuto,
• S. Coluzzi,
• ...
• L. Boldrini,
• P.F. Bassi,
• E. Sacco

An image classification algorithm for prostate cancer diagnosis on multiparametric transrectal ultrasound – Preliminary results of a prospective multicenter diagnostic accuracy trial

• A. Jager,
• A.W. Posterma,
• M.J. Hagens,
• ...
• H.P. Beerlage,
• M. Mischi,
• J.R. Oddens

Outcomes of transrectal ultrasound guided prostate biopsies amenable lesions on MRI prostate

• M.T. Awan,
• L. Amanya

Our prostate cancer detection rate in patients with reported PIRADS-3 lesions

• H.C. Kuvan,
• B. Akgül,
• E. Arda

Our target-directed prostate biopsy results in patients with PIRADS>2 lesions

• B. Akgül,
• H.C. Kuvan,
• E. Arda

Change in prostate cancer staging patterns in the post-COVID-19 era

• J. Lima,
• B. Sepodes,
• J.A. Pereira,
• ...
• B. Parada,
• V. Sousa,
• A. Figueiredo

Prior imaging impact of patients submitted to brachytherapy for prostate cancer

• D. Vieira E Brito,
• J.A. Pereira,
• M. Lourenço,
• R. Godinho,
• B. Pereira,
• C. Rabaça

Evaluation of a clinical acceptability of artificial intelligence automatic contouring: An example of the use of artificial intelligence in prostate radiotherapy

• S. Catli Dinc,
• M. Akmansu,
• H. Bora,
• ...
• Ö.P. Erpolat,
• E. Karahacioglu,
• E. Şentürk

Pathological and clinical predictors of biochemical recurrence after radical prostatectomy

• M. Vilaça,
• J. Correia Pinto,
• M. Costa,
• ...
• F. Estevinho,
• F. Carmo Reis,
• A. Mesquita

Prostate artery embolisation for symptomatic giant prostate hyperplasia

• A-J. Nassour,
• R. Copping,
• V. Bhoopathy,
• ...
• P. Mancuso,
• J. Catt,
• G. Schlaphoff

Re-irradiation for recurrent prostate cancer after low dose rate brachytherapy: A new option of care?

• O. Munoz Munoz,
• E. Gomis Selles,
• P. Cabrera Roldán,
• B.D. Delgado León,
• J.L. López Guerra

Radiium systemic radiotherapy – 223 patients with mCRPC. Experience of the Republic of Bashkortostan

• A. Sultanbaev,
• K. Menshikov,
• S. Musin,
• ...
• I. Menshikova,
• A. Izmailov,
• M. Sultanbaev

177Lu-DOTA-TLX591 safety, biodistribution and dosimetry study (ProstACT-SELECT)

• K. O’Byrne,
• D. Meyrick,
• N. Patel,
• F. Fantino,
• C. Hayward

Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer

• P. Rajwa,
• D. Pfister,
• C. Rieger,
• ...
• T. Persigehl,
• S.F. Shariat,
• A. Heidenreich

Rectal spacers for prostate cancer: Real world data and potential uses

• I. Watts,
• A. Gore,
• S. Needleman,
• ...
• A. Roy,
• C. Harthill,
• M. Prentice

What are the disease outcomes for patients with oligometastatic prostate cancer treated with Stereotactic Ablative Radiotherapy (SABR)?

• A. Bald,
• A. Henry,
• F. Slevin,
• L. Murray,
• P. Dickinson

The impact of Choline-PET/CT and PSMA-PET/TC on biochemistry failure management after radical prostatectomy

• C. Munoz Calahorro,
• I. Rivero Belenchón,
• J. Moliner Malaxechevarría,
• E. Cabello Gómez,
• C.B. Congregado Ruiz,
• R.A. Medina López

Our experiences in clinical T2 renal tumor in patients with nephron-saving surgery single center

• M.O. Atacer,
• B. Bilir,
• T. Aktoz,
• E. Arda

Multiparametric MRI for bladder cancer staging. Initial experience of our clinic

• L. Mitrakas,
• I. Zachos,
• G. Chasiotis,
• A. Karatzas,
• A. Oeconomou,
• V. Tzortzis

A UK urological cancer centre cystectomy service - What lessons can we learn?

• D. Dawam,
• H. Motiwala,
• M. Abdalazeez,
• ...
• T. Carr,
• M. Dooldeniya,
• H. Hegarty

The role of 18F-FDG-PET/CT for staging patients with high risk non-muscle invasive bladder cancer before radical cystectomy

• N. van Ginkel,
• E.J. Van Gennep,
• T.N. Boellaard,
• ...
• A.N. Vis,
• B.W.G. Van Rhijn,
• L.S. Mertens

Beneficial effects of intraoperative cell salvage on allogenic blood transfusion and recurrence free survival in radical cystectomy patients

• C. Onyeze

Ki67 and FOXC1-based complementary diagnostic for neoadjuvant cisplatin-based chemotherapy predicts response and improved survival in muscle-invasive bladder cancer

• P. Ray,
• T. Ray,
• R. Hussa

Prognostic significance of neutrophil to lymphocyte ratio in neoadjuvant chemotherapy in bladder cancer

• D.S. Magalhaes,
• M. Vilaça,
• M. Costa,
• D. Silva,
• H. Magalhães

A cross-sectional study on the role of posterior acoustic shadow width in ultrasound in determining stone size in urolithiasis

• M.J. Raja Iyub,
• S. Prasad,
• S. Sudhakaran,
• K. Senthil,
• G. Ramesh,
• K. Anandha

Chengai score: a novel tool using the preoperative computed tomography parameters in determining ureteroscopic lithotripsy outcomes in ureteric stones

• M.J. Raja Iyub,
• S. Prasad,
• S. Sudhakaran,
• S. Kumar,
• G. Ramesh,
• A. Kumar